Fierce Pharma

AUGUST 28, 2023

Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher. Danaher Corporation is picking up all outstanding shares of Abcam for $24 apiece. Both companies’ boards unanimously approved the decision, Danaher and Abcam said Monday.

98

98

Pharmaceutical Technology

MARCH 8, 2023

Global science and technology innovator Danaher has entered a strategic collaboration with the University of Pennsylvania for cellular immunotherapies to address manufacturing challenges impacting cell therapy uptake. The post Danaher and University of Pennsylvania partner for cell therapies appeared first on Pharmaceutical Technology.

Communication 97

Communication FDA 97

European Pharmaceutical Review

MARCH 19, 2024

The research explained that companies are looking to reduce manufacturing costs and increase productivity, which is driving implementation of this type of bioprocessing. Merck KGaA Sartorius AG Danaher Corporation Entegris, Inc. the global continuous bioprocessing market is expected to value $1,067.8 million by 2031.

Documentation 68

Documentation 68

STAT

FEBRUARY 1, 2024

That’s where Bluebird Bio, a company that exists solely for that purpose, could be instructive. Novavax is on thin ice Novavax, the company whose corporate missteps repeatedly sidelined an effective Covid-19 vaccine, is relying on demand for booster doses to remain solvent.

Vaccines 104

Vaccines Communication Insurance 104

European Pharmaceutical Review

OCTOBER 6, 2022

To overcome these obstacles, mergers and acquisitions and partnerships are two of the main ways companies are currently meeting consumer demand and widening their customer base. Key market players include Beckman Coulter, Becton, Dickinson and Company, Biolog, Inc., bioMerieux S.A.,

Compounding 87

Compounding 87

PharmaShots

MAY 10, 2023

Shots: Driven by constant innovation and life-changing technological advances, medical device companies have integrated a holistic approach to diagnosis and therapeutics. in 2022, medical device companies are anticipated to touch the astronomical threshold of $965.2B. The company’s 2022 revenue surged by 4.32% vs 2021.

Nursing Homes 40

Nursing Homes Hospitals FDA Communication 40

pharmaphorum

AUGUST 9, 2021

Osstem Implants, Straumann Group, Nobel Biocare, Zimmer Biomet, Dentsply Sirona, Henry Schein and Danaher Corporation are some of the many leading companies dealing in the production of dental implants in the global market. About the author.

Hospitals 98

Hospitals 98